Fig. 1From: Combination immunotherapy and radiotherapy causes an abscopal treatment response in a mouse model of castration resistant prostate cancerCastration-resistant prostate cancer is successfully treated by immune checkpoint inhibitor combined with radiotherapy, with effects on the irradiated and unirradiated tumors, and increased survival. a-d. Myc-CaP tumor graft volumes (a and b) and survival (c and d) for mice treated with immune checkpoint inhibitor monotherapy and given in combination with XRT to the leg graft. Significantly decreased tumor graft volume and significantly increased median survival was observed. Error bars represent ± SEMBack to article page